Sleep Test Coverage Policy, ResMed/Respironics Talks Could Awaken Market
This article was originally published in The Gray Sheet
Executive Summary
ResMed plans to work with Respironics to generate data that will raise the public and professional profile of sleep-disordered breathing (SDB) devices, which have an estimated $600 mil. U.S. market potential